Direct-to-Patient Supply: Industry Perception and Future Trends
Summary: Catalent and Fierce Pharma surveyed 234 individuals involved in clinical supply and clinical operations to better understand the industry perception around importance of having a direct-to-patient option for the delivery of clinical supplies in both current and future studies, including perceived benefits and potential barriers to its use.